Hippo‐YAP signaling pathway: A new paradigm for cancer therapy

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 10, 2015-11 ,pp. : 2275-2286

John Wiley & Sons Inc

Access to resources Recommend Favorite

Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 67-74

Karger

Access to resources Recommend Favorite

The Hippo pathway in chemotherapeutic drug resistance

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2767-2773

John Wiley & Sons Inc

Access to resources Recommend Favorite

Par‐aPKC‐dependent and ‐independent mechanisms cooperatively control cell polarity, Hippo signaling, and cell positioning in 16‐cell stage mouse embryos

By  

DEVELOPMENT, GROWTH & DIFFERENTIATION (ELECTRONIC), Vol. 57, Iss. 8, 2015-10 ,pp. : 544-556

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cover Photograph: Hippo signaling controls cell fates in preimplantation mouse embryos. Slightly different mechanisms operate in regulation of Hippo signaling between 16‐cell stage and early blastocyst stage with more than 32 cells. Panels show the confocal images of the 16‐cell (left panel) and early blastocyst (right panel) stage embryos stained with phosphorylated Ezrin/Radixin/Moesin (magenta), a marker for apical domain and cell polarization, and the Hippo pathway coactivator Yap (green). In the early blastocysts, cell position regulates cell polarization through the Par‐aPKC system, and cell polarity controls Hippo signaling. Therefore, all the outer cells are polarized and exhibit nuclear Yap. In contrast, at the 16‐cell stage, Par‐aPKC‐independent mechanism and asymmetric cell division are also involved in regulation of cell polarization. Therefore, some outer cells are apolar and show cytoplasmic Yap.

By  

DEVELOPMENT, GROWTH & DIFFERENTIATION (ELECTRONIC), Vol. 57, Iss. 8, 2015-10 ,pp. : i-i

John Wiley & Sons Inc

Access to resources Recommend Favorite